WOUNDCHEK™ Laboratories is focused on the development of novel wound diagnostics products to help improve therapeutic outcomes in wound care.
Clinical experts agree the use of point of care wound diagnostic devices could reduce the cost of ineffective treatment and delayed healing by being able to target the right therapy, on the right patient, at the right time. A resulting financial benefit to health care systems can be achieved through significant reduction of the
expenses associated with poor targeting of treatment, delayed healing, and avoidable complications.
WOUNDCHEK™ Laboratories launched the word’s first and only point of care test to detect EPA (elevated protease activity) in chronic wounds in 2012, and over the past several years has become a recognized leader in wound diagnostics.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Airebank Mill, Gargrave,north Yorkshire Bd23 3rx,united Kingdom
- Industry
- Medical Device
- Website
- woundchek.com
- Keywords
- London.
- HQ
- Gargrave, North Yorkshire
Woundchek Laboratories Questions
Woundchek Laboratories's website is woundchek.com
Woundchek Laboratories's LinkedIn profile is https://www.linkedin.com/company/woundchek-laboratories
Woundchek Laboratories has
5 employees.
View email and phone details for 5
employees at Woundchek Laboratories.
Woundchek Laboratories's industry is
Medical Device
Woundchek Laboratories's top competitors are
Rush Oak Park Hospital,
Chasm Advanced Materials, Inc.,
Fleet Bioprocessing,
Rhinostics Inc.,
Plethy,
Firstkind Ltd - Geko® Device,
Cytoswim Ltd,
Modern Dental Pacific,
Sheppard Moscow,
Msu Department Of Communication.
Woundchek Laboratories's categories are Medical Device
Woundchek Laboratories's founding year is 2013
